glioblastoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
glioblastoma
Jul 23, 2024, 00:16 |
Blog
Research brings hope, advancing Glioblastoma treatments - Mayo Clinic
Mayo Clinic’s shared a post on LinkedIn: “Globally, approximately 300,000 people are diagnosed each year…
Jul 21, 2024, 12:10 |
Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 19, 2024, 12:40 |
Blog
Dolphins Cancer Challenge and StacheStrong Partnership Advances Brain Cancer Research at Sylvester Comprehensive Cancer Center
A $1 million commitment supports glioblastoma studies at the new Sylvester Brain Tumor Institute. Dolphins…
Jul 19, 2024, 00:37 |
Blog
Rachael Kittleson: I am raising awareness on GBM in honor of my daughter
Rachael Kittleson, Senior Director of Community at the National Brain Tumor Society, shared on LinkedIn:…
Jul 18, 2024, 07:19 |
Blog
Glioblastoma Awareness Day!
GLIOMATCH posted on LinkedIn: "Today is Glioblastoma Awareness Day (GBM Day) On 17 July 2024,…
Jul 17, 2024, 14:25 |
Opinion
Impactful stats about Glioblastoma - National Brain Tumor Society
National Brain Tumor Society shared on X: "Glioblastoma (GBM) is the deadliest type of brain…
Jul 17, 2024, 05:15 |
Blog
The critical role of caregivers in improving patient outcomes - We Trials
We Trials shared a post on X: . "On Glioblastoma Awareness Day, we highlight the…
Jul 13, 2024, 04:45 |
Positive
Richard Scolyer: No evidence of recurrence of my glioblastoma!
Richard Scolyer shared a post on X: “I couldn’t be happier that my MRI brain…
Jul 9, 2024, 01:11 |
Insight
Richard Scolyer: Using my illness to push boundaries to obtain knowledge about glioblatoma
Richard Scolyer shared a post on X: “I’m proud of being able to use my…
Jul 8, 2024, 13:00 |
Insight
MD Anderson Research Highlights
Featuring a novel drug for glioblastoma, resources to understand tumor evolution, a lower-dose radiation approach,…
Jul 7, 2024, 02:28 |
Insight
Research on malignant brain tumors is evolving Sylvester Brain Tumor Institute
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Research on malignant brain tumors is rising to…
Jul 4, 2024, 16:09 |
Blog
A deep dive into immune responses to cancer vaccines plus immunotherapy - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: . "David Reardon, MD, is doing a…
Jul 3, 2024, 23:45 |
Insight
A four-patient trial testing a unique type of mRNA cancer vaccine - NCI
National Cancer Institute (NCI) shared a post on LinkedIn: "Recent results from several small clinical…
Jun 26, 2024, 08:52 |
Blog
Richard Scolyer: Amazing advances in medicine over the past half century
Richard Scolyer shared on X: "Medicine has made many amazing advances over the past half…
Jun 21, 2024, 16:06 |
Cancer Types
Glioblastoma in Children: What patients and caregivers should know about
What is Glioblastoma? Pediatric glioblastoma is a rare and aggressive brain tumor that primarily affects children. It accounts for approximately 3% of…
Jun 20, 2024, 14:08 |
Cancer Types
Glioblastoma in Adults: What patients should know about
Glioblastoma, also known as glioblastoma multiforme, is the most aggressive and common type of primary…
Jun 19, 2024, 12:33 |
Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 15, 2024, 06:57 |
Blog
Zouina Sarfraz: I will be lead guest editing a special collection titled 'Towards Universal Cancer Care'
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: “I am pleased to announce that…
Jun 2, 2024, 15:19 |
Societies
Wafik S. El-Deiry: This morning I wore my nerdy DNA double helix tie
Wafik S. El-Deiry recently shared a post on LinkedIn: "This morning I wore my nerdy…
Jun 1, 2024, 11:12 |
Blog
Manmeet Ahluwalia: Beyond thrilled to receive the notice of Award of our second NIH/NCI R01, $3.4 million grant
Manmeet Ahluwalia, Chief of Medical Oncology, Deputy Director and Chief Scientific Officer of Miami Cancer…
May 30, 2024, 11:14 |
Blog
Pallavi Tiwari: Stoked to receive the NOA for our new $3.4M NIH/NCI R01 project
Pallavi Tiwari, Associate Professor at the UW School of Medicine and Public Health, recently shared…
May 30, 2024, 02:01 |
Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 27, 2024, 08:43 |
Insight
Diane-Isis Nyob: A new video that explains the complex mode of action of our drug for glioblastoma
Diane-Isis Nyob, Senior Market Intelligence Analyst at Debiopharm International SA, recently shared a post by…
May 24, 2024, 14:50 |
Insight
A new paper on VC-resist glioblastoma cell state out in Nature Communications
A groundbreaking new open-access paper was published in the prestigious journal, Nature Communications, titled "VC-resist…
May 24, 2024, 12:25 |
Blog
Claude Bajada: We are thrilled to announce the upcoming launch of the BRIAN project
Claude Bajada, Senior Lecturer at the University of Malta, shared on LinkedIn: "We are thrilled…
May 23, 2024, 13:01 |
Insight
A neural epigenetic signature is prognostic in patients with glioblastoma - Nature Medicine
Nature Medicine recently shared a post on X: "A neural epigenetic signature detectable via plasma…
May 20, 2024, 07:05 |
Blog
Marcela Maus: Expanding our clinical research around CAR-T therapy
Marcela Maus, Director of Cellular Immunotherapy, MGH Cancer Center Associate Professor at Harvard Medical School,…
May 16, 2024, 09:15 |
Blog
Richard Scolyer: No sign of recurrence of glioblastoma
Richard Scolyer, CoMedical Director at Melanoma Institute Australia, shared a post on X: "I had brain…
May 14, 2024, 09:19 |
Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 11, 2024, 12:13 |
Insight
Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: "Comprehensive mutational scanning of EGFR…
May 10, 2024, 17:31 |
Blog
The Sylvester Brain Tumor Institute launched by Sylvester Comprehensive Cancer Center to Personalize Brain Cancer Treatment
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine announced establishment…
May 7, 2024, 11:18 |
Blog
Richard Scolyer: I had further experimental treatment for my 'brain cancer' glioblastoma
Richard Scolyer, Co-Medical Director at Melanoma Institute Australia, shared on X/Twitter: "On Monday, I had further…
Apr 13, 2024, 13:34 |
Blog
Vivek Subbiah: An editorial describes the science behind one strategy using a CAR T cell
Vivek Subbiah shared on X/Twitter: "Most patients diagnosed with glioblastoma die within a year, so innovative…
Apr 8, 2024, 17:38 |
Blog
Abhishek Garg: Excellent commentary on our recent study on innovative dendritic cell vaccines and how to overcome unanticipated resistance
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Apr 4, 2024, 06:45 |
Insight
Anna Golebiewska: New findings on how glioblastoma educates tumor microenvironment,
Anna Golebiewska, Principal Investigator at NORLUX Lab at Luxembourg Institute of Health, shared on X/Twitter:…
Mar 31, 2024, 14:23 |
Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 23, 2024, 14:45 |
Insight
Article summaries by Erman Akkus: BMI and cancer prognosis and billiary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter: 1. ''BMI, weight…
Mar 20, 2024, 22:29 |
Positive
Richard Scolyer: Amazingly, my latest MRI brain scan shows no recurrence 10 months since my glioblastoma
Richard Scolyer, Co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University of…
Mar 19, 2024, 20:14 |
Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 18, 2024, 09:48 |
Insight
Wafik S. El-Deiry: Important preliminary signal of transient response in GBM with CAR-T cells
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared a post…
Mar 17, 2024, 15:26 |
Blog
Bryan D. Choi: NEJM published our clinical study of a novel CART Cell in patients with Glioblastoma
Bryan D. Choi, Neurosurgeon and Scientist at Massachusetts General Hospital, posted on X/Twitter: "Today, NEJM…
Mar 17, 2024, 13:22 |
Drugs
Lombardi Giuseppe: Prospective study on regorafenib in recurrent glioblastoma
Lombardi Giuseppe, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared on…
Mar 13, 2024, 09:23 |
Blog
Katy Rezvani: Important study showing the promise of locoregional delivery of CAR-T cells in glioblastoma
Katy Rezvani, Chief, Section of Cellular Therapy at the Department of Stem Cell Transplantation and…
Mar 12, 2024, 09:51 |
Blog
Angela Mastronuzzi: Happy to share our multicenter retrospective study on a large cohort of GBM-LTS patients from nine Italian institutions
Angela Mastronuzzi shared on LinkedIn: “Happy to share our just published study! "Clinicopathological and molecular landscape…
Feb 19, 2024, 09:26 |
Insight
Justin Stebbing: Amazing work to identify PANK4 as a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma
Justin Stebbing shared on LinkedIn: "Huge congratulations to an amazing team led by Georgios Giamas,…
Jan 27, 2024, 07:20 |
Blog
Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!
Richard Scolyer, CoMedical Director at Melanoma Institute Australia and Surgical Pathologist at Royal Prince Alfred…
Jan 25, 2024, 17:25 |
Insight
Radhika Mathur: Glioblastoma from a 3D whole-tumor perspective. My 5+ years of postdoctoral work
Radhika Mathur, Research Scientist at UCSF, recently shared on X/Twitter: "Thrilled to finally share my…
Jan 25, 2024, 08:51 |
Insight
Vivek Subbiah: Tissue Agnostic Precision Medicine in Primary brain tumors like glioblastoma?
Vivek Subbiah shared on LinkedIn: "Hot off the press. What is the impact of Tissue Agnostic…
Jan 21, 2024, 07:28 |
Insight
Abhishek Garg: Innovative reverse translational approach helped us discover a novel dual-organ immuno-resistance pathway
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Oct 7, 2023, 16:23 |
Blog
We are delighted to announce the official start of LEGATO Project - EORTC - European Organisation for Research and Treatment of Cancer
The European Organisation for Research and Treatment of Cancer (EORTC), shared a post by LEGATO…
Sep 22, 2023, 18:38 |
Insight
Angela Mastronuzzi: Proud of my team at Ospedale Pediatrico Bambino Gesù for this paper published with MDPI.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at the Bambino Gesù Children's Hospital, shared on LinkedIn:…
Sep 19, 2023, 20:03 |
Drugs
Gabriela Kramer-Marek: I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
Sep 12, 2023, 19:42 |
Career
Manmeet Ahluwalia: Congratulations Ahmad Ozair for the prestigious Rosenblum-Mahaley award!
Manmeet Ahluwalia, Chief Scientific Officer at the Miami Cancer Institute, shared a post by Ahmad…
Sep 3, 2023, 17:25 |
Insight
Sangeeta Goswami: Some publications are extra special because of the emotional value attached to it.
Sangeeta Goswami, Assistant Professor at the MD Anderson Cancer Center, recently tweeted: "Some publications are…
Aug 27, 2023, 18:14 |
Blog
A new form of screening may improve survival rates among people with glioblastoma by helping to identify those most likely to benefit from certain types of Immunotherapy. - The Institute of Cancer Research
Aug 13, 2023, 17:51 |
Blog
Gustavo Viani: Hypo Radiationtherapy shows comparable long term results to the standard of care for Glioblastoma!
Gustavo A. Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao…
Jul 26, 2023, 21:28 |
Stories
Join donors like David in leading the charge to advance immunotherapy research - Cancer Research Institute (CRI)
“In February 2004, I received a message over the phone no parent ever wants to…
Jun 25, 2023, 17:23 |
Drugs
We found that 5-aminolevulinic acid (5-ALA) and intraoperative MRI (iMRI) offer similar surgical outcomes in glioblastoma resection, with no superiority of iMRI
In a post by Sotirios Bisdas on Linkedin, it says, "I am thrilled to share…
Jun 25, 2023, 16:45 |
Blog
This is fantastic news for IDH-mutant glioma patients - Tyler E Miller
This is fantastic news for IDH-mutant glioma patients !! We are not used to seeing…
All:
59
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube